Works by Frenel, Jean-Sébastien


Results: 53
    1
    2

    Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40569-9
    By:
    • de Moura, Alexandre;
    • Vuagnat, Perrine;
    • Renouf, Benjamin;
    • Pierga, Jean-Yves;
    • Loirat, Delphine;
    • Vaflard, Pauline;
    • Lafayolle de la Bruyère, Charline;
    • Chaumard-Billotey, Natacha;
    • Hajjaji, Nawale;
    • Ladoire, Sylvain;
    • Dabakuyo, Sandrine;
    • Patsouris, Anne;
    • Frenel, Jean Sébastien;
    • Nicolai, Vincent;
    • Alexandre, Marie;
    • Dohollou, Nadine;
    • Grenier, Julien;
    • Bourien, Heloïse;
    • Bidard, François-Clément
    Publication type:
    Article
    3

    Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40569-9
    By:
    • de Moura, Alexandre;
    • Vuagnat, Perrine;
    • Renouf, Benjamin;
    • Pierga, Jean-Yves;
    • Loirat, Delphine;
    • Vaflard, Pauline;
    • Lafayolle de la Bruyère, Charline;
    • Chaumard-Billotey, Natacha;
    • Hajjaji, Nawale;
    • Ladoire, Sylvain;
    • Dabakuyo, Sandrine;
    • Patsouris, Anne;
    • Frenel, Jean Sébastien;
    • Nicolai, Vincent;
    • Alexandre, Marie;
    • Dohollou, Nadine;
    • Grenier, Julien;
    • Bourien, Heloïse;
    • Bidard, François-Clément
    Publication type:
    Article
    4

    Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study.

    Published in:
    Cancers, 2023, v. 15, n. 4, p. 1191, doi. 10.3390/cancers15041191
    By:
    • François-Martin, Hélène;
    • Lardy-Cléaud, Audrey;
    • Pistilli, Barbara;
    • Levy, Christelle;
    • Diéras, Véronique;
    • Frenel, Jean-Sébastien;
    • Guiu, Séverine;
    • Mouret-Reynier, Marie-Ange;
    • Mailliez, Audrey;
    • Eymard, Jean-Christophe;
    • Petit, Thierry;
    • Ung, Mony;
    • Desmoulins, Isabelle;
    • Augereau, Paule;
    • Bachelot, Thomas;
    • Uwer, Lionel;
    • Debled, Marc;
    • Ferrero, Jean-Marc;
    • Clatot, Florian;
    • Goncalves, Anthony
    Publication type:
    Article
    5

    Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH -Mutant Gliomas: A French POLA Network Study.

    Published in:
    Cancers, 2022, v. 14, n. 22, p. 5509, doi. 10.3390/cancers14225509
    By:
    • Montégut, Coline;
    • Guillamo, Jean-Sébastien;
    • Ducray, François;
    • Dehais, Caroline;
    • Cohen-Jonathan Moyal, Elisabeth;
    • Desenclos, Christine;
    • Petit, Antoine;
    • Seizeur, Romuald;
    • Bekaert, Lien;
    • Gaultier, Claude;
    • Motuo Fotso, Marie Jeannette;
    • Blonski, Marie;
    • Frenel, Jean-Sébastien;
    • Vauléon, Elodie;
    • Langlois, Olivier;
    • Noel, Georges;
    • Carpentier, Antoine F.;
    • Di Stefano, Anna Luisa;
    • Bronnimann, Charlotte;
    • Figarella-Branger, Dominique
    Publication type:
    Article
    6
    7
    8
    9
    10

    Ribosome biogenesis‐based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group.

    Published in:
    Molecular Oncology, 2023, v. 17, n. 1, p. 27, doi. 10.1002/1878-0261.13340
    By:
    • Mourksi, Nour‐El‐Houda;
    • Dalban, Cécile;
    • Colombe‐Vermorel, Amélie;
    • Odeyer, Laetitia;
    • Simioni, Valentin;
    • Frenel, Jean‐Sébastien;
    • Fabbro, Michel;
    • Bazan, Fernando;
    • Abadie‐Lacourtoisie, Sophie;
    • Coquan, Elodie;
    • Martinez, Séverine;
    • Garin, Gwenaelle;
    • Tabone‐Eglinger, Séverine;
    • Treilleux, Isabelle;
    • Chabaud, Sylvie;
    • Pérol, David;
    • Ray‐Coquard, Isabelle;
    • Heudel, Pierre‐Etienne;
    • Diaz, Jean‐Jacques;
    • Marcel, Virginie
    Publication type:
    Article
    11

    Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.

    Published in:
    2022
    By:
    • Jacot, William;
    • Lusque, Amélie;
    • Vicier, Cécile;
    • Mailliez, Audrey;
    • de La Motte Rouge, Thibault;
    • Cabel, Luc;
    • Levy, Christelle;
    • Patsouris, Anne;
    • Desmoulins, Isabelle;
    • Uwer, Lionel;
    • Thery, Jean-Christophe;
    • Robain, Mathieu;
    • Caron, Olivier;
    • Tredan, Olivier;
    • Filleron, Thomas;
    • Frenel, Jean-Sébastien;
    • Delaloge, Suzette
    Publication type:
    journal article
    12

    Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes.

    Published in:
    Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1114435
    By:
    • Cheeseman, Sue;
    • Levick, Bethany;
    • Sopwith, Will;
    • Fenton, Hayley;
    • Eun Ji Nam;
    • Dong Kyu Kim;
    • Subin Lim;
    • Martin, Elodie;
    • Frenel, Jean-Sébastien;
    • Bocquet, François;
    • Kubelac, Paul;
    • Achimas-Cadariu, Patriciu;
    • Vlad, Catalin;
    • Chevrier, Marion;
    • Rouzier, Roman;
    • Carton, Matthieu;
    • Savva-Bordalo, Joana;
    • Magalhães, Marta;
    • Borges, Marina;
    • Wolf, Andrea
    Publication type:
    Article
    13
    14

    Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 9, p. 1670, doi. 10.1093/neuonc/noae053
    By:
    • Roth, Patrick;
    • Gorlia, Thierry;
    • Reijneveld, Jaap C;
    • Vos, Filip de;
    • Idbaih, Ahmed;
    • Frenel, Jean-Sébastien;
    • Rhun, Emilie Le;
    • Sepulveda, Juan Manuel;
    • Perry, James;
    • Masucci, G Laura;
    • Freres, Pierre;
    • Hirte, Hal;
    • Seidel, Clemens;
    • Walenkamp, Annemiek;
    • Lukacova, Slavka;
    • Meijnders, Paul;
    • Blais, Andre;
    • Ducray, Francois;
    • Verschaeve, Vincent;
    • Nicholas, Garth
    Publication type:
    Article
    15
    16
    17
    18

    Clinicopathological characteristics and prognosis of breast cancer patients with isolated central nervous system metastases in the multicentre ESME database.

    Published in:
    Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221077082
    By:
    • Carausu, Marcela;
    • Carton, Matthieu;
    • Cabel, Luc;
    • Patsouris, Anne;
    • Levy, Christelle;
    • Verret, Benjamin;
    • Pasquier, David;
    • Debled, Marc;
    • Gonçalves, Anthony;
    • Desmoulins, Isabelle;
    • Lecouillard, Isabelle;
    • Bachelot, Thomas;
    • Ferrero, Jean-Marc;
    • Eymard, Jean-Christophe;
    • Mouret-Reynier, Marie-Ange;
    • Chevrot, Michaël;
    • De Maio, Eleonora;
    • Uwer, Lionel;
    • Frenel, Jean-Sébastien;
    • Leheurteur, Marianne
    Publication type:
    Article
    19

    Pharmacokinetic drug evaluation of abemaciclib for advanced breast cancer.

    Published in:
    Expert Opinion on Drug Metabolism & Toxicology, 2019, v. 15, n. 2, p. 85, doi. 10.1080/17425255.2019.1559816
    By:
    • Robert, Marie;
    • Frenel, Jean-Sébastien;
    • Bourbouloux, Emmanuelle;
    • Berton Rigaud, Dominique;
    • Patsouris, Anne;
    • Augereau, Paule;
    • Gourmelon, Carole;
    • Campone, Mario
    Publication type:
    Article
    20
    21
    22
    23
    24

    Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer.

    Published in:
    International Journal of Cancer, 2020, v. 146, n. 2, p. 439, doi. 10.1002/ijc.32606
    By:
    • Ray‐Coquard, Isabelle;
    • Cibula, David;
    • Mirza, Mansoor R.;
    • Reuss, Alexander;
    • Ricci, Caterina;
    • Colombo, Nicoletta;
    • Koch, Horst;
    • Goffin, Frédéric;
    • González‐Martin, Antonio;
    • Ottevanger, Petronella B.;
    • Baumann, Klaus;
    • Bjørge, Line;
    • Lesoin, Anne;
    • Burges, Alexander;
    • Rosenberg, Per;
    • Gropp‐Meier, Martina;
    • Harrela, Maija;
    • Harter, Philipp;
    • Frenel, Jean‐Sébastien;
    • Minarik, Tomas
    Publication type:
    Article
    25
    26
    27

    Standard 6-week chemoradiation for elderly patients with newly diagnosed glioblastoma.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01537-3
    By:
    • Vaugier, Loïg;
    • Ah-Thiane, Loïc;
    • Aumont, Maud;
    • Jouglar, Emmanuel;
    • Campone, Mario;
    • Colliard, Camille;
    • Doucet, Ludovic;
    • Frenel, Jean-Sébastien;
    • Gourmelon, Carole;
    • Robert, Marie;
    • Martin, Stéphane-André;
    • Riem, Tanguy;
    • Roualdes, Vincent;
    • Campion, Loïc;
    • Mervoyer, Augustin
    Publication type:
    Article
    28
    29

    Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2022, v. 191, n. 1, p. 191, doi. 10.1007/s10549-021-06382-6
    By:
    • Corbaux, Pauline;
    • Lardy-Cleaud, Audrey;
    • Alexandre, Marie;
    • Fontanilles, Maxime;
    • Lévy, Christelle;
    • Viansone, Alessandro Adriano;
    • Mailliez, Audrey;
    • Debled, Marc;
    • Goncalves, Anthony;
    • Le Du, Fanny;
    • Lerebours, Florence;
    • Ferrero, Jean-Marc;
    • Eymard, Jean-Christophe;
    • Mouret-Reynier, Marie-Ange;
    • Petit, Thierry;
    • Frenel, Jean-Sébastien;
    • Dalenc, Florence;
    • Courtinard, Coralie;
    • Chaix, Marie;
    • Bachelot, Thomas
    Publication type:
    Article
    30

    Association of Endocrine Therapy for HR+/ERBB2+ Metastatic Breast Cancer With Survival Outcomes.

    Published in:
    JAMA Network Open, 2022, v. 5, n. 12, p. e2247154, doi. 10.1001/jamanetworkopen.2022.47154
    By:
    • Carausu, Marcela;
    • Carton, Matthieu;
    • Diéras, Véronique;
    • Petit, Thierry;
    • Guiu, Séverine;
    • Gonçalves, Anthony;
    • Augereau, Paule;
    • Ferrero, Jean Marc;
    • Levy, Christelle;
    • Ung, Mony;
    • Desmoulins, Isabelle;
    • Debled, Marc;
    • Bachelot, Thomas;
    • Pistilli, Barbara;
    • Frenel, Jean-Sébastien;
    • Mailliez, Audrey;
    • Chevrot, Michaël;
    • Cabel, Luc
    Publication type:
    Article
    31

    Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France.

    Published in:
    JAMA Network Open, 2022, v. 5, n. 9, p. e2231170, doi. 10.1001/jamanetworkopen.2022.31170
    By:
    • de Calbiac, Ombline;
    • Lusque, Amélie;
    • Mailliez, Audrey;
    • Bachelot, Thomas;
    • Uwer, Lionel;
    • Mouret-Reynier, Marie-Ange;
    • Emile, George;
    • Jouannaud, Christelle;
    • Gonçalves, Anthony;
    • Patsouris, Anne;
    • Diéras, Véronique;
    • Leheurteur, Marianne;
    • Petit, Thierry;
    • Cottu, Paul;
    • Ferrero, Jean-Marc;
    • D'Hondt, Véronique;
    • Desmoulins, Isabelle;
    • Mourato-Ribeiro, Joana;
    • Martin, Anne-Laure;
    • Frenel, Jean-Sébastien
    Publication type:
    Article
    32
    33

    Efficacy of buparlisib in treating breast cancer.

    Published in:
    Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 18, p. 2007, doi. 10.1080/14656566.2017.1410139
    By:
    • Robert, Marie;
    • Frenel, Jean-Sébastien;
    • Bourbouloux, Emmanuelle;
    • Berton Rigaud, Dominique;
    • Patsouris, Anne;
    • Augereau, Paule;
    • Gourmelon, Carole;
    • Campone, Mario
    Publication type:
    Article
    34

    Vinflunine for the treatment of breast cancer.

    Published in:
    Expert Opinion on Pharmacotherapy, 2016, v. 17, n. 13, p. 1817, doi. 10.1080/14656566.2016.1217991
    By:
    • Gourmelon, Carole;
    • Bourien, Héloïse;
    • Augereau, Paule;
    • Patsouris, Anne;
    • Frenel, Jean-Sébastien;
    • Campone, Mario
    Publication type:
    Article
    35

    Olaparib for the treatment of breast cancer.

    Published in:
    Expert Opinion on Investigational Drugs, 2017, v. 26, n. 6, p. 751, doi. 10.1080/13543784.2017.1318847
    By:
    • Robert, Marie;
    • Frenel, Jean-Sébastien;
    • Gourmelon, Carole;
    • Patsouris, Anne;
    • Augereau, Paule;
    • Campone, Mario
    Publication type:
    Article
    36

    Emerging PARP inhibitors for treating breast cancer.

    Published in:
    Expert Opinion on Emerging Drugs, 2018, v. 23, n. 3, p. 211, doi. 10.1080/14728214.2018.1527900
    By:
    • Robert, Marie;
    • Patsouris, Anne;
    • Frenel, Jean-Sébastien;
    • Gourmelon, Carole;
    • Augereau, Paule;
    • Campone, Mario
    Publication type:
    Article
    37

    Pertuzumab for the treatment of breast cancer.

    Published in:
    2020
    By:
    • Robert, Marie;
    • Frenel, Jean-Sébastien;
    • Bourbouloux, Emmanuelle;
    • Berton Rigaud, Dominique;
    • Patsouris, Anne;
    • Augereau, Paule;
    • Gourmelon, Carole;
    • Campone, Mario
    Publication type:
    journal article
    38
    39
    40
    41
    42

    Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study.

    Published in:
    Oncologist, 2022, v. 27, n. 5, p. 414, doi. 10.1093/oncolo/oyac023
    By:
    • Garnier, Louis;
    • Vidal, Chrystelle;
    • Chinot, Olivier;
    • Moyal, Elisabeth Cohen-Jonathan;
    • Djelad, Apolline;
    • Bronnimann, Charlotte;
    • Bekaert, Lien;
    • Taillandier, Luc;
    • Frenel, Jean-Sébastien;
    • Langlois, Olivier;
    • Colin, Philippe;
    • Menei, Philippe;
    • Dhermain, Frédéric;
    • Carpentier, Catherine;
    • Gerazime, Aurélie;
    • Curtit, Elsa;
    • Figarella-Branger, Dominique;
    • Dehais, Caroline;
    • Ducray, François
    Publication type:
    Article
    43
    44

    CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients.

    Published in:
    Breast Cancer (13406868), 2023, v. 30, n. 2, p. 315, doi. 10.1007/s12282-022-01426-1
    By:
    • Bailleux, Caroline;
    • Arnaud, Antoine;
    • Frenel, Jean-Sébastien;
    • Chabaud, Sylvie;
    • Bachelot, Thomas;
    • You, Benoît;
    • Stefani, Laëtitia;
    • Tixidre, Claire Garnier;
    • Simon, Hélène;
    • Beal-Ardisson, Dominique;
    • Jacquin, Jean-Philippe;
    • Del Piano, Francesco;
    • Lortholary, Alain;
    • Cornea, Claudiu;
    • Greilsamer, Charlotte;
    • Largillier, Rémy;
    • Brocard, Fabien;
    • Legouffe, Eric;
    • Atlassi, Mustapha;
    • Hardy-Bessard, Anne-Claire
    Publication type:
    Article
    45

    Evaluating everolimus for the treatment of breast cancer.

    Published in:
    Expert Opinion on Pharmacotherapy, 2023, v. 24, n. 10, p. 1105, doi. 10.1080/14656566.2023.2214677
    By:
    • Moreau-Bachelard, Camille;
    • Robert, Marie;
    • Gourmelon, Carole;
    • Bourbouloux, Emmanuelle;
    • Patsouris, Anne;
    • Frenel, Jean-Sébastien;
    • Campone, Mario
    Publication type:
    Article
    46
    47
    48
    49

    Adjustment of young women with breast cancer after chemotherapy: A mediation model of emotional competence via emotional distress.

    Published in:
    Psycho-Oncology, 2022, v. 31, n. 5, p. 848, doi. 10.1002/pon.5876
    By:
    • Baudry, Anne‐Sophie;
    • Yakimova, Sonya;
    • Congard, Anne;
    • Untas, Aurélie;
    • Guiu, Séverine;
    • Lefeuvre‐Plesse, Claudia;
    • Loustalot, Catherine;
    • Guillemet, Cécile;
    • Segura‐Djezzar, Carine;
    • Savoye, Aude‐Marie;
    • Coussy, Florence;
    • Frenel, Jean‐Sébastien;
    • Vanlemmens, Laurence;
    • Christophe, Véronique
    Publication type:
    Article
    50